Australia approves first tablet form of Wegovy for weight loss
Audio narration · Coming soon
A tablet version of Wegovy, a peptide medication used for weight loss, has been approved for the first time in Australia. This approval marks a new option compared to the existing weight-loss injections of Wegovy. The development could impact how patients manage obesity treatment in Australia.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews